Related Experiment Video
Updated: Jul 16, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
Hemorrhagic upper extremity complications from tissue plasminogen activator.
Kathleen A Crick1, John C Crick, Michael T Pulley
1St Vincent's Medical Center, Jacksonville, FL 32204, USA. drcrick@bellsouth.net
Intravenous tissue plasminogen activator (tPA) can cause upper extremity hemorrhages in acute myocardial infarction patients. Careful monitoring of IV sites and lines is crucial to prevent bleeding complications.
Area of Science:
- Cardiology
- Vascular Medicine
- Pharmacology
Background:
- Fibrinolytic therapy with intravenous tissue plasminogen activator (tPA) is a critical treatment for acute myocardial infarction.
- tPA is also utilized in managing acute nonhemorrhagic stroke.
- Understanding potential complications is essential for patient safety.
Observation:
- A study observed five patients aged 63-79 experiencing upper extremity hemorrhagic complications.
- These complications arose during fibrinolytic therapy for acute myocardial infarction.
- Hemorrhages ranged from superficial hematomas to severe cases like compartment syndrome.
Findings:
- Three patients developed superficial hematomas.
- One patient experienced a deep subcutaneous hematoma with skin necrosis.
- Another patient presented with compartment syndrome, posterior interosseous nerve palsy, and significant intramuscular bleeding.
Implications:
- The findings highlight the risk of upper extremity hemorrhage with intravenous tPA.
- Caution is advised at IV sites, central lines, arterial catheterization, and with pneumatic tourniquets.
- This underscores the need for vigilant monitoring and preventative measures during tPA therapy.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Hemorrhagic Stroke ll: Pathophysiology
Venous Thrombosis IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins

